TSWM
JAZZ icon

Tyler-Stone Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Tyler-Stone Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6
Closed -$1K – 882
2022
Q1 		$1K Hold
6
– – ﹤0.01% 794
2021
Q4 		$1K Buy
+6
New +$789 ﹤0.01% 868

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

Tyler-Stone Wealth Management's JAZZ Position: Q2 2022 in Review

Tyler-Stone Wealth Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2022, closing a stake of 6 shares — an estimated $1K sold.

Tyler-Stone Wealth Management first reported a position in JAZZ in Q4 2021 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 468 funds tracked by Wall St. Rank hold JAZZ as of Q2 2022.

  • Tyler-Stone Wealth Management reported no remaining Jazz Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Tyler-Stone Wealth Management sold 6 Jazz Pharmaceuticals shares in Q2 2022, an estimated $1K.
  • Tyler-Stone Wealth Management first reported a position in Jazz Pharmaceuticals in Q4 2021 and held it in 2 quarters.
  • Tyler-Stone Wealth Management's Jazz Pharmaceuticals position peaked at $1K in Q1 2022.
  • 468 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2022.

Based on Tyler-Stone Wealth Management's 13F filing for Q2 2022, filed 11 Aug 2022.